Cynata has signed a worldwide licence agreement with TekCyte Pty Ltd for TekCyte’s novel wound dressing technology for use in Cynata’s upcoming diabetic foot ulcer trial (short scroll down)
Cynata CEO Dr Ross Macdonald appears on Kalkine TV’s “Expert Corner” to discuss the Company’s quarterly results and provides an update on its MEND trial and worldwide exclusive licence agreement with TekCyte Pty Ltd.
Channel 9 Health Reporter Gabriella Rogers explores the potential therapeutic benefits of Cynata’s MSC product in this serious disease and reviews the SCULpTOR trial with Professor David Hunter
Addressing The Challenges Of MSCs Will Reveal A Bright Future For This Regenerative Medicine Modality.
Celebrating Fantastic Women in Regenerative Medicine: An Interview With Cynata’s Dr Suzanne Lipe, Vice President of Partner Engagement.
Read More at RegMedNet